Send to

Choose Destination
Int J Antimicrob Agents. 2007 Sep;30(3):210-2. Epub 2007 Jun 12.

Community-acquired methicillin-resistant Staphylococcus aureus (MRSA): new issues for infection control.

Author information

Department of Internal Medicine, Medical College of Virginia Campus, Virginia Commonwealth University, and Medical College of Virginia Hospitals, 1101 East Broad Street, P.O. Box 980663, Richmond, VA 23298, USA.


The emergence and clonal expansion of strains of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) have created new challenges with their entrance to hospitals. The increased virulence of CA-MRSA in concert with the depressed immunity of inpatients may cause added morbidity and mortality expected from healthcare-associated infections. Questions about changing prophylactic and empirical therapy as well as the use of intravenous immunoglobulin for life-threatening infections are addressed.

[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center